Release Date: 11/10/12 13:52 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 320.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%